Landai Technology Group Corp., Ltd. (SHE:002765)

Theseus Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	708.46	710.18	675.38	650.8	489.92	452.59
Trading Asset Securities	-	-	-	1.94	16.88	0.86
Cash & Short-Term Investments	708.46	710.18	675.38	652.74	506.8	453.46
Cash Growth	36.59%	5.15%	3.47%	28.80%	11.76%	58.16%
Accounts Receivable	1,149	1,269	941	870.23	998.48	713.93
Other Receivables	17.68	8.81	6.42	25.35	18.4	13.29
Receivables	1,167	1,277	947.66	895.57	1,018	728.32
Inventory	813.16	730.72	759.71	646.28	736.69	546.21
Prepaid Expenses	-	-	4.65	3.91	-	-
Other Current Assets	88.98	73.67	103.98	43.14	57.05	62.94
Total Current Assets	2,777	2,792	2,491	2,242	2,319	1,791
Property, Plant & Equipment	1,945	1,990	1,745	1,241	1,097	1,118
Long-Term Investments	8.79	3.79	3.9	4.06	4.64	5.49
Goodwill	131.67	131.67	131.67	501.17	501.17	501.17
Other Intangible Assets	258.2	261.62	278.38	261.87	273.82	346.79
Long-Term Deferred Tax Assets	113.19	117.59	127.02	116.85	108.57	99.36
Long-Term Deferred Charges	73.49	75.51	94.19	38.01	32.89	44.16
Other Long-Term Assets	221.64	103.03	207.65	345.95	36.39	37.3
Total Assets	5,530	5,476	5,079	4,751	4,373	3,943
Accounts Payable	1,346	1,400	1,319	933.93	1,003	843.14
Accrued Expenses	39.51	73.38	64.57	53.74	89.2	56.52
Short-Term Debt	351.12	341.14	240.95	437.1	304.25	287.19
Current Portion of Long-Term Debt	195.28	195.72	42.05	45	20	45
Current Portion of Leases	-	12.38	11.59	26.26	22.38	-
Current Income Taxes Payable	20.4	0.85	2.17	5	14.64	12.01
Current Unearned Revenue	17.81	9.48	8.25	44.55	9.92	11.46
Other Current Liabilities	23.59	52.78	28.7	43.99	48.3	50.66
Total Current Liabilities	1,994	2,085	1,718	1,590	1,512	1,306
Long-Term Debt	519.64	420.61	438.99	284.29	145	59.5
Long-Term Leases	10.29	12.39	22.85	32.4	36.76	-
Long-Term Unearned Revenue	210.24	212.23	243.77	289.28	339.54	439.2
Long-Term Deferred Tax Liabilities	12.85	15.23	18.6	23	1.62	1.61
Other Long-Term Liabilities	239.98	239.98	239.98	239.98	251	300
Total Liabilities	2,987	2,986	2,682	2,459	2,286	2,106
Common Stock	652.13	652.13	655.79	583.05	582.63	575.18
Additional Paid-In Capital	1,546	1,546	1,555	1,087	1,065	1,045
Retained Earnings	320.21	268.04	176.37	573.86	418.56	208.51
Treasury Stock	-	-	-12.68	-26.87	-25.78	-
Total Common Equity	2,519	2,466	2,375	2,217	2,041	1,829
Minority Interest	24.44	23.23	22.19	75.22	46.71	8.24
Shareholders' Equity	2,543	2,490	2,397	2,292	2,088	1,837
Total Liabilities & Equity	5,530	5,476	5,079	4,751	4,373	3,943
Total Debt	1,076	982.25	756.43	825.06	528.39	391.69
Net Cash (Debt)	-367.86	-272.07	-81.05	-172.32	-21.59	61.77
Net Cash Per Share	-0.56	-0.42	-0.13	-0.30	-0.04	0.12
Filing Date Shares Outstanding	652.13	652.13	702.54	649.13	575.18	575.18
Total Common Shares Outstanding	652.13	652.13	702.54	575	575.18	575.18
Working Capital	783.89	706.55	773.75	652.07	806.94	484.95
Book Value Per Share	3.86	3.78	3.38	3.86	3.55	3.18
Tangible Book Value	2,129	2,073	1,965	1,454	1,266	980.58
Tangible Book Value Per Share	3.26	3.18	2.80	2.53	2.20	1.70
Buildings	-	486.3	348.9	347.36	338.84	338.33
Machinery	-	2,477	2,229	1,598	1,470	1,407
Construction In Progress	-	201.55	133.64	128.33	45.45	58.93

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.